Acupuncture for Alzheimer's in gene carriers and non-carriers
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether acupuncture can help people with Alzheimer's disease. Researchers will compare results in people who carry the APOE e4 gene and those who don't, to see if the treatment works differently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 85 years old.
- You have been diagnosed with mild to moderate Alzheimer's disease.
- An MRI shows atrophy (shrinkage) in the memory-related parts of your brain.
- Your memory problems are not caused by other conditions like stroke or vitamin deficiency.
- You are not taking blood thinners such as warfarin or heparin, and you can safely have an MRI (no pacemaker or claustrophobia).
- You have not had acupuncture or used a pacemaker in the last 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether acupuncture can improve symptoms in people with Alzheimer’s disease. You may qualify if you have memory and thinking changes consistent with Alzheimer’s and meet imaging and brain-scan score requirements.
This trial tests a device that sends gentle electrical pulses to a nerve in the neck, which may help improve memory and thinking in people with mild to moderate Alzheimer's disease. It is for patients who have had a positive amyloid PET scan and are currently taking a stable dose of a cholinesterase inhibitor medication.
This trial tests whether a special form of a dietary fat called tricaprilin can help people with mild-to-moderate Alzheimer's disease. It may provide an alternative or add-on to current treatments to help with memory and thinking.
This study enrolls people with no memory impairment, mild memory problems, or mild Alzheimer’s dementia to test how brain scans and cognitive tests relate to Alzheimer’s disease. It may help by contributing to better early diagnosis and by letting you see whether you fit into the study’s imaging and blood-test pathway.
This study looks at how a person’s APOE gene relates to early brain and health changes that could lead to Alzheimer’s. If you are not currently having memory or thinking problems, you may be asked to do brain scans, cognitive testing, and blood plus a spinal fluid sample to support research.
This study tests a non-invasive brain stimulation technique called transcranial alternating current stimulation (tACS) to see if it can improve memory and thinking in people with early Alzheimer's disease. It may offer a new way to help manage symptoms.
Hear when a new Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.